Novel traditional Chinese medicinal preparation for resisting leucopenia and preparation method and application thereof

Abstract

The invention belongs to the technical field of traditional Chinese medicine pharmacy, and relates to a traditional Chinese medicinal preparation for resisting leucopenia and a preparation method and application thereof. The preparation is prepared from the following main components by weight proportion: main ingredients including 10-50 g of ginseng, 20-60 g of rhizoma atractylodis, 30-70 g of rice vinegar and 80-120 g of iron vitriol; and accessories including a proper amount of liquor and a proper amount of distilled water. The traditional Chinese medicinal preparation is simple for administration, has obvious curative effect, and no toxic or side effect, and is applicable to malignant tumor patients with leucopenia caused by chemotherapy and radiotherapy.

Description

technical field [0001] The invention belongs to the pharmaceutical technical field of traditional Chinese medicine, and relates to a pill for increasing the number of white blood cells and a preparation method thereof. Background technique [0002] Radiotherapy and chemotherapy, as one of the main methods for treating malignant tumors, have long been recognized by the medical community. However, severe side effects caused by radiotherapy and chemotherapy. Such as nausea and vomiting, anorexia, oral and esophageal ulcers, which make patients unbearable and persistent. This serious side effect has not been resolved so far. Patients often stop the course of radiotherapy and chemotherapy, which greatly affects the curative effect and survival time of patients. How to promote the production of white blood cells has become an extremely important issue for patients to complete radiotherapy and chemotherapy. [0003] Leukopenia caused by radiotherapy and chemotherapy can lead t...

AI Technical Summary

Problems solved by technology

[0003] Leukopenia caused by radiotherapy and chemotherapy can lead to severe infection and even death. For this serious consequence, CSF (genetic recombinant granulocyte colony stimulating Factor) promotes the differentiation and proliferation of hematopoietic granulocytes, stimulates the growth and release of granulocytes, increases the granulocytes in the peripheral blood, prevents severe infection, and reduces the mortality rate. The use of CSF is reliable, but it has the following disadvantages: 1) It cannot be used for M3 leukemia patients Use; 2) There are certain side effects, such as allergies can not be used; 3) It is an injection type in use, which will bring pain to patients; 4) Most scholars believe that people with uncontrolled leukemia should not use it, because CSF is naive to leukemia patients The immature white blood cells of type 1 leukemia also have the effect of promoting growth, which can prevent the recurrence of leukemia or aggravate the disease.